Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
TFS HealthScience (TFS), a global contract research organization (CRO), announced the appointment of long-standing member of the company, Miriam Martin , as Vice President of Business Development, Clinical Development Services (CDS).
read more
CluePoints, a provider of quality management solutions for clinical trials, launched a new Post-COVID Trial Assurance Solution. The solution offers study teams the opportunity to assess the quality of their data within a defined timeline and with ...
read more
Tuesday, February 04, 2025
Eleva and 3PBIOVIAN announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva’s technology platform.
read more
Tuesday, February 18, 2014
BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced the opening of a new Biosimilar Centre of Excellence in Glasgow. The new facility ...
read more
Monday, February 09, 2015
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, will introduce a new label + cap combination anti-counterfeiting solution to the U.S. market at INTERPHEX NYC 2015 Booth #1053, ...
read more
Tuesday, September 19, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has hired Benedikt von Braunmuehl as Chief Executive Officer (CEO).
read more
Monday, November 06, 2023
Sygnature Discovery has incorporated an Azenta compound management storage system into its capabilities, enabling the storage of customer libraries as well. High-fidelity hit finding is a crucial initial step in successful drug discovery projects, ...
read more
The company announced its successful approval by the FDA for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (...
read more
Monday, November 03, 2025
Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug ...
read more
The opioid tragedy has become one of the defining public health crises of modern times.
read more
Monday, February 06, 2017
Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early ...
read more
Incyte and Syros Pharmaceuticals have entered into a target discovery, research collaboration and option agreement.
read more
Thursday, August 08, 2019
Purdue has sold its Treyburn, North Carolina, plant to Novo Nordisk for an undisclosed sum, according to an announcement Purdue CEO Craig Landau sent to the plant’s employees.
read more
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
read more
Eurofins Discovery announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned leaders from the pharmaceutical and biotechnology industries to gain strategic insights to address the unmet needs in drug ...
read more